Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 9Recruiting 3Withdrawn 2Unknown 2Terminated 2Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Thoracic 1Breast 1

Conditions

Breast Neoplasms 47Rectal Neoplasms 29Stomach Neoplasms 24Colorectal Neoplasms 24Triple Negative Breast Neoplasms 18Neoplasm Metastasis 10Colonic Neoplasms 10Nasopharyngeal Carcinoma 9Locally Advanced Rectal Cancer 7Esophageal Neoplasms 7Biliary Tract Neoplasms 7Pancreatic Neoplasms 5Brain Neoplasms 5Adenocarcinoma Of Esophagus 5Adenocarcinoma 5Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Neuroendocrine Tumors 3HER2-positive Breast Cancer 3Gastrointestinal Neoplasms 3Cholangiocarcinoma 3Advanced Solid Tumors 3Recurrence 2Neoplasm, Residual 2Meningeal Neoplasms 2Locally Advanced Colorectal Cancer 2Esophageal Squamous Cell Carcinoma 2Early Low Rectal Cancer 2Colorectal Cancer Metastatic 2

Interventions

pembrolizumab 61Cisplatin 38Carboplatin 24Radiotherapy 22Cetuximab 19Paclitaxel 17Magnetic Resonance Spectroscopy 17Specimen Handling 12Docetaxel 12Fluorouracil 11Nivolumab 10tislelizumab 9Surgical Procedures, Operative 8Standard of Care 7Radiotherapy, Intensity-Modulated 7Radiation 7cemiplimab 6Platinum 6Chemoradiotherapy 6Biopsy 61,2-diaminocyclohexaneplatinum II citrate 6toripalimab 5atezolizumab 5Drug Therapy 5Blood Specimen Collection 5130-nm albumin-bound paclitaxel 5dostarlimab 4Taxes 4Surveys and Questionnaires 4Ipilimumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Squamous Cell Carcinoma of Head and Neck × Capecitabine × Clear all
NCT05785741 2026-04-06

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

DualityBio Inc.

Phase 1/2 Recruiting
1,000 enrolled
BreastHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT06494995 2025-06-04

AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy

Fudan University

Phase 2 Recruiting
52 enrolled
Head & Neck

Diabetes Mellitus, Insulin-Dependent, 12, Squamous Cell Carcinoma of Head and Neck

NCT05044117 2022-03-03

Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)

Sun Yat-sen University

Phase 3 Recruiting
220 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡